EuroAPI's site in Brindisi, Italy (Credit: EuroAPI)

Eu­roAPI’s blue­print for ‘lean­er’ op­er­a­tions in­cludes drop­ping prod­ucts, po­ten­tial lay­offs and sites put on ice

Eu­roAPI is count­ing on 2024 to be its “year of tran­si­tion” as the small mol­e­cule pro­duc­er plans to dis­con­tin­ue API as­sets, po­ten­tial­ly make lay­offs and “moth­ball” or di­vest sites. Its re­struc­tur­ing project, dubbed FO­CUS-27, will be dri­ven by its new­ly ap­point­ed CEO, Lud­wig de Mot.

Nonethe­less, the stock $EAPI.PA of Eu­roAPI — a Sanofi API spin­off — plum­met­ed by as much as 45% on Thurs­day af­ter the com­pa­ny de­tailed its plans on Wednes­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.